Caribou Biosciences (CRBU) Other Non-Current Assets (2020 - 2026)

Caribou Biosciences (CRBU) has 7 years of Other Non-Current Assets data on file, last reported at $2.1 million in Q1 2026.

• On a quarterly basis, Other Non-Current Assets fell 57.62% year-over-year to $2.1 million in Q1 2026; TTM through Mar 2026 was $2.1 million, a 57.62% decrease from a year earlier, with the FY2025 full-year figure at $2.2 million, down 60.15% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $2.1 million, down from $2.2 million in the prior quarter.
• Over the last five years, Other Non-Current Assets for CRBU reached as high as $5.5 million in Q4 2024 and fell as low as $1.3 million in Q2 2022.
• Historically, Other Non-Current Assets has averaged $2.5 million across 5 years, with a median of $1.6 million in 2024.
• Across the five-year window, Other Non-Current Assets sank 61.63% in 2022 and surged 248.11% in 2024, its largest moves.
• Year by year, Other Non-Current Assets stood at $1.5 million in 2022, then grew by 3.12% to $1.6 million in 2023, then jumped by 248.11% to $5.5 million in 2024, then tumbled by 60.15% to $2.2 million in 2025, then decreased by 2.86% to $2.1 million in 2026.
• Per Business Quant data, the three most recent Other Non-Current Assets figures were $2.1 million in Q1 2026, $2.2 million in Q4 2025, and $3.8 million in Q3 2025.